Patients and Users for Reasonable Policy
(PURP)

Researchers ran through various efforts to regulate cannabis concentrates which had been supported by some stakeholders before taking questions on how to influence legislators and the public.

Three cannabis proposals were advanced during the committee’s final executive session before a crucial legislative deadline, and members had questions for a social equity bill sponsor.

Legislation to create permits for some rental operators to give a cannabis product to guests over 21 received positive testimony as lawmakers questioned costs and implications of the change.

Bills to restrict cannabis concentrates had the support of some health officials and an anti-legalization group, but industry members and a consumer advocate tagged them “prohibition bill[s]."

Interstate commerce legislation was advanced in the Senate but delayed in the House, and cannabis packaging law changes drew support from the advocates who showed up.

A bill expanding sales and possession limits for low-THC beverages got support from two industry stakeholders, but a consumer advocate dissented over suspected environmental implications.

Sharply divided testimony and at times emotional appeals were presented during a public hearing on legislation to dilute cannabis concentrates and raise the legal purchase age to 25.

Testimony in the fiscal committee hearing on cannabis home grow was mostly positive with over one hundred people signed in support, while a small group voiced concerns about youth access and normalization.

Written testimony submitted regarding HB 1019, a bill dealing with adult cannabis cultivation, revealed a large amount of encouraging feedback and a couple of dissenting critiques.

An extensive briefing by WSLCB staff on past cannabis business licensing windows provoked a lively Q&A on the prospective social equity program application process.